Skip to main content
Top
Published in: European Journal of Epidemiology 7/2017

01-07-2017 | META-ANALYSIS

A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan

Authors: Takumi Hirata, Daisuke Sugiyama, Shin-ya Nagasawa, Yoshitaka Murakami, Shigeyuki Saitoh, Akira Okayama, Hiroyasu Iso, Fujiko Irie, Toshimi Sairenchi, Yoshihiro Miyamoto, Michiko Yamada, Shizukiyo Ishikawa, Katsuyuki Miura, Hirotsugu Ueshima, Tomonori Okamura, for the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan (EPOCH-JAPAN) Research Group

Published in: European Journal of Epidemiology | Issue 7/2017

Login to get access

Abstract

Low levels of serum high-density lipoprotein cholesterol (HDL-C) have been shown to be associated with increased risk of coronary heart disease (CHD). However, because this is usually observed in the context of other lipid abnormalities, it is not known whether isolated low serum HDL-C levels are an independent risk factor for CHD. We performed a large pooled analysis in Japan using data from nine cohorts with 41,206 participants aged 40–89 years who were free of cardiovascular disease at baseline. We divided participants into three groups: isolated low HDL-C, non-isolated low HDL-C, and normal HDL-C. Cohort-stratified Cox proportional hazards models were used to estimate multivariate-adjusted hazard ratios (HRs) for death due to CHD, ischemic stroke, and intracranial cerebral hemorrhage; during a 12.9-year follow-up, we observed 355, 286, and 138 deaths, respectively, in these groups. Non-isolated low HDL-C was significantly associated with increased risk of CHD compared with normal HDL-C (HR 1.37, 95 % confidence interval (CI) 1.04–1.80); however, isolated low HDL-C was not. Although isolated low HDL-C was significantly associated with decreased risk of CHD (HR 0.51, 95 % CI 0.29–0.89) in women, it was significantly associated with increased risk of intracranial cerebral hemorrhage in all participants (HR 1.62, 95 % CI 1.04–2.53) and in men (HR 2.00, 95 % CI 1.04–3.83). In conclusion, isolated low HDL-C levels are not associated with increased risk of CHD in Japan. CHD risk may, therefore, be more strongly affected by serum total cholesterol levels in this population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med. 1977;62:707–14.CrossRefPubMed Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med. 1977;62:707–14.CrossRefPubMed
2.
go back to reference Castelli WP, Garrison RJ, Wilson PW, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 1986;256:2835–8.CrossRefPubMed Castelli WP, Garrison RJ, Wilson PW, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 1986;256:2835–8.CrossRefPubMed
3.
go back to reference Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arterioscler Thromb Vasc Biol. 1988;8:737–41.CrossRef Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arterioscler Thromb Vasc Biol. 1988;8:737–41.CrossRef
4.
go back to reference Yaari S, Goldbourt U, Even-Zohar S, et al. Associations of serum high density lipoprotein and total cholesterol with total, cardiovascular, and cancer mortality in a 7-year prospective study of 10,000 men. Lancet. 1981;1:1011–5.CrossRefPubMed Yaari S, Goldbourt U, Even-Zohar S, et al. Associations of serum high density lipoprotein and total cholesterol with total, cardiovascular, and cancer mortality in a 7-year prospective study of 10,000 men. Lancet. 1981;1:1011–5.CrossRefPubMed
5.
go back to reference Jacobs DR Jr, Mebane IL, Bangdiwala SI, et al. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol. 1990;131:32–47.CrossRefPubMed Jacobs DR Jr, Mebane IL, Bangdiwala SI, et al. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol. 1990;131:32–47.CrossRefPubMed
6.
go back to reference Kitamura A, Iso H, Naito Y, et al. High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation. 1994;89:2533–9.CrossRefPubMed Kitamura A, Iso H, Naito Y, et al. High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation. 1994;89:2533–9.CrossRefPubMed
7.
go back to reference Desprĕs JP, Lemieux I, Dagenais GR, et al. HDL-cholesterol as a marker of coronary heart disease risk: the Quĕbec cardiovascular study. Atherosclerosis. 2000;153:263–72.CrossRefPubMed Desprĕs JP, Lemieux I, Dagenais GR, et al. HDL-cholesterol as a marker of coronary heart disease risk: the Quĕbec cardiovascular study. Atherosclerosis. 2000;153:263–72.CrossRefPubMed
8.
go back to reference Rashid S, Genest J. Effect of obesity on high-density lipoprotein metabolism. Obesity (Silver Spring). 2007;15:2875–8.CrossRef Rashid S, Genest J. Effect of obesity on high-density lipoprotein metabolism. Obesity (Silver Spring). 2007;15:2875–8.CrossRef
9.
go back to reference Austin MA, King MC, Vranizan KM, et al. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation. 1990;82:495–506.CrossRefPubMed Austin MA, King MC, Vranizan KM, et al. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation. 1990;82:495–506.CrossRefPubMed
10.
go back to reference Subedi BH, Joshi PH, Jones SR, et al. Current guidelines for high-density lipoprotein cholesterol in therapy and future directions. Vasc Health Risk Manag. 2014;10:205–16.PubMedPubMedCentral Subedi BH, Joshi PH, Jones SR, et al. Current guidelines for high-density lipoprotein cholesterol in therapy and future directions. Vasc Health Risk Manag. 2014;10:205–16.PubMedPubMedCentral
11.
go back to reference Pirillo A, Norata GD, Catapano AL. Treating high density lipoprotein cholesterol (HDL-C): quantity versus quality. Curr Pharm Des. 2013;19:3841–57.CrossRefPubMed Pirillo A, Norata GD, Catapano AL. Treating high density lipoprotein cholesterol (HDL-C): quantity versus quality. Curr Pharm Des. 2013;19:3841–57.CrossRefPubMed
12.
go back to reference Cziraky MJ, Watson KE, Talbert RL. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the management care setting. J Manag Care Pharm. 2008;14:S3–28.PubMed Cziraky MJ, Watson KE, Talbert RL. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the management care setting. J Manag Care Pharm. 2008;14:S3–28.PubMed
13.
go back to reference Huxley RR, Barzi F, Lam TH, et al. Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease. An individual participant data meta-analysis of 23 studies in the Asia–Pacific region. Circulation. 2011;124:2056–64.CrossRefPubMed Huxley RR, Barzi F, Lam TH, et al. Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease. An individual participant data meta-analysis of 23 studies in the Asia–Pacific region. Circulation. 2011;124:2056–64.CrossRefPubMed
14.
go back to reference Yamamoto A, Horibe H, Mabuchi H, et al. Analysis of serum lipid levels in Japanese men and women according to body mass index. Increase in risk of atherosclerosis in postmenopausal women. Research group on serum lipid survey 1990 in Japan. Atherosclerosis. 1999;143:55–73.CrossRefPubMed Yamamoto A, Horibe H, Mabuchi H, et al. Analysis of serum lipid levels in Japanese men and women according to body mass index. Increase in risk of atherosclerosis in postmenopausal women. Research group on serum lipid survey 1990 in Japan. Atherosclerosis. 1999;143:55–73.CrossRefPubMed
15.
go back to reference Murakami Y, Hozawa A, Okamura T, et al. Relation of blood pressure and all-cause mortality in 180,000 Japanese participants: pooled analysis of 13 cohort studies. Hypertension. 2008;51:1483–91.CrossRefPubMed Murakami Y, Hozawa A, Okamura T, et al. Relation of blood pressure and all-cause mortality in 180,000 Japanese participants: pooled analysis of 13 cohort studies. Hypertension. 2008;51:1483–91.CrossRefPubMed
16.
go back to reference Murakami Y, Miura K, Okamura T, et al. Population attributable numbers and fractions of deaths due to smoking: a pooled analysis of 180,000 Japanese. Prev Med. 2011;52:60–5.CrossRefPubMed Murakami Y, Miura K, Okamura T, et al. Population attributable numbers and fractions of deaths due to smoking: a pooled analysis of 180,000 Japanese. Prev Med. 2011;52:60–5.CrossRefPubMed
17.
go back to reference Program National Cholesterol Education. (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–421. Program National Cholesterol Education. (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–421.
18.
go back to reference Collaboration Prospective Studies, Lewington S, Whitlock G, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370:1829–39.CrossRef Collaboration Prospective Studies, Lewington S, Whitlock G, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370:1829–39.CrossRef
19.
go back to reference Nagasawa SY, Okamura T, Iso H, et al. Relationship between serum total cholesterol level and cardiovascular disease stratified by sex and age group: a pooled analysis of 65,594 individuals from 10 cohort studies in Japan. J Am Heart Assoc. 2012;1:e001974.CrossRefPubMedPubMedCentral Nagasawa SY, Okamura T, Iso H, et al. Relationship between serum total cholesterol level and cardiovascular disease stratified by sex and age group: a pooled analysis of 65,594 individuals from 10 cohort studies in Japan. J Am Heart Assoc. 2012;1:e001974.CrossRefPubMedPubMedCentral
20.
go back to reference Briel M, Ferreira-Gonzalez I, You JJ, et al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. BMJ. 2009;338:b92.CrossRefPubMedPubMedCentral Briel M, Ferreira-Gonzalez I, You JJ, et al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. BMJ. 2009;338:b92.CrossRefPubMedPubMedCentral
21.
go back to reference Patel A, Barzi F, Jamrozik K, et al. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation. 2004;110:2678–86.CrossRefPubMed Patel A, Barzi F, Jamrozik K, et al. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation. 2004;110:2678–86.CrossRefPubMed
22.
go back to reference Morrison A, Hokanson JE. The independent relationship between triglycerides and coronary heart disease. Vasc Health Risk Manag. 2009;5:89–95.PubMedPubMedCentral Morrison A, Hokanson JE. The independent relationship between triglycerides and coronary heart disease. Vasc Health Risk Manag. 2009;5:89–95.PubMedPubMedCentral
23.
go back to reference AIM-HIGH investigators, Boden WE, Probstfield JL, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011;365:2255–67.CrossRef AIM-HIGH investigators, Boden WE, Probstfield JL, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011;365:2255–67.CrossRef
24.
go back to reference Keene D, Price C, Shun-Shin MJ, et al. Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients. BMJ. 2014;349:g4379.CrossRefPubMedPubMedCentral Keene D, Price C, Shun-Shin MJ, et al. Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients. BMJ. 2014;349:g4379.CrossRefPubMedPubMedCentral
25.
go back to reference Amarenco P, Labreuche J, Touboul PJ. High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review. Atherosclerosis. 2008;196:489–96.CrossRefPubMed Amarenco P, Labreuche J, Touboul PJ. High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review. Atherosclerosis. 2008;196:489–96.CrossRefPubMed
26.
go back to reference Soyama Y, Miura K, Morikawa Y, et al. High-density lipoprotein cholesterol and risk of stroke in Japanese men and women: the Oyabe Study. Stroke. 2003;34:863–8.CrossRefPubMed Soyama Y, Miura K, Morikawa Y, et al. High-density lipoprotein cholesterol and risk of stroke in Japanese men and women: the Oyabe Study. Stroke. 2003;34:863–8.CrossRefPubMed
27.
go back to reference Zhang X, Patel A, Horibe H, et al. Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol. 2003;32:563–72.CrossRefPubMed Zhang X, Patel A, Horibe H, et al. Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol. 2003;32:563–72.CrossRefPubMed
28.
go back to reference Ebrahim S, Sung J, Song YM, et al. Serum cholesterol, hemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study. BMJ. 2006;333:22.CrossRefPubMedPubMedCentral Ebrahim S, Sung J, Song YM, et al. Serum cholesterol, hemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study. BMJ. 2006;333:22.CrossRefPubMedPubMedCentral
29.
go back to reference Wang X, Li S, Bai Y, et al. Inverse association of plasma level of high-density lipoprotein cholesterol with intracerebral hemorrhage. J Lipid Res. 2011;52:1747–54.CrossRefPubMedPubMedCentral Wang X, Li S, Bai Y, et al. Inverse association of plasma level of high-density lipoprotein cholesterol with intracerebral hemorrhage. J Lipid Res. 2011;52:1747–54.CrossRefPubMedPubMedCentral
30.
go back to reference Ueshima H, Iida M, Shimamoto T, et al. Multivariate analysis of risk factors for stroke. Eight-year follow-up study of farming villages in Akita, Japan. Prev Med. 1980;9:722–40.CrossRefPubMed Ueshima H, Iida M, Shimamoto T, et al. Multivariate analysis of risk factors for stroke. Eight-year follow-up study of farming villages in Akita, Japan. Prev Med. 1980;9:722–40.CrossRefPubMed
31.
go back to reference Iso H, Jacobs DR Jr, Wentworth D, et al. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989;320:904–10.CrossRefPubMed Iso H, Jacobs DR Jr, Wentworth D, et al. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989;320:904–10.CrossRefPubMed
32.
go back to reference Collaboration Emerging Risk Factors, Danesh J, Ergou S, et al. The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol. 2007;22:839–69.CrossRef Collaboration Emerging Risk Factors, Danesh J, Ergou S, et al. The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol. 2007;22:839–69.CrossRef
33.
go back to reference Satoh M, Ohkubo T, Asayama K, et al. Combined effect of blood pressure and total cholesterol levels on long-term risks of subtypes of cardiovascular death: evidence for Cardiovascular Prevention from Observational Cohorts in Japan. Hypertension. 2015;65:517–24.CrossRefPubMed Satoh M, Ohkubo T, Asayama K, et al. Combined effect of blood pressure and total cholesterol levels on long-term risks of subtypes of cardiovascular death: evidence for Cardiovascular Prevention from Observational Cohorts in Japan. Hypertension. 2015;65:517–24.CrossRefPubMed
34.
go back to reference Puddey IB. Low serum cholesterol and the risk of cerebral hemorrhage. Atherosclerosis. 1996;119:1–6.CrossRefPubMed Puddey IB. Low serum cholesterol and the risk of cerebral hemorrhage. Atherosclerosis. 1996;119:1–6.CrossRefPubMed
35.
go back to reference Reed DM. The paradox of high risk of stroke in populations with low risk of coronary heart disease. Am J Epidemiol. 1990;131:579–88.CrossRefPubMed Reed DM. The paradox of high risk of stroke in populations with low risk of coronary heart disease. Am J Epidemiol. 1990;131:579–88.CrossRefPubMed
Metadata
Title
A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan
Authors
Takumi Hirata
Daisuke Sugiyama
Shin-ya Nagasawa
Yoshitaka Murakami
Shigeyuki Saitoh
Akira Okayama
Hiroyasu Iso
Fujiko Irie
Toshimi Sairenchi
Yoshihiro Miyamoto
Michiko Yamada
Shizukiyo Ishikawa
Katsuyuki Miura
Hirotsugu Ueshima
Tomonori Okamura
for the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan (EPOCH-JAPAN) Research Group
Publication date
01-07-2017
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 7/2017
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-016-0203-1

Other articles of this Issue 7/2017

European Journal of Epidemiology 7/2017 Go to the issue